BL Pharmtech acquires 10.55% of Kwangdong Health Bio
비엘팜텍
065170
Signal Score
Historical Avg Return (5d)
+0.00%
Data Coverage
100%n=659
Risk-adjusted indicator based on 659 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Acquired Shares: 727,272 Shares
- • Acquisition Amount: 1,047,271,680 KRW
- • % of Total Equity: 10.55%
- • Post-Acquisition Ownership: 13.96% (1,770,958 Shares)
- • Target Company 2025 Revenue: 66,980M KRW
AI Analysis Summary
BL Pharmtech Corp. decided to acquire 727,272 shares of Kwangdong Health Bio Co., Ltd. for 1,047,271,680 KRW, representing 10.55% of its equity. This increases BL Pharmtech's total stake to 13.96% (1,770,958 shares) in Kwangdong Health Bio, a health functional food manufacturer with 2025 revenue of 66,980M KRW and a net loss of 640M KRW. The acquisition aims to strengthen business cooperation for new product launches. The acquisition is a strategic investment, not establishing a controlling interest.
How This Event Is Evaluated
M&A / Merger Evaluation
M&A events are evaluated by assessing deal size relative to company scale, strategic rationale, financing structure, and integration risk.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Deal size relative to market value
- Strategic fit and synergy potential
- Financing structure (cash, stock, debt)
- Regulatory and integration risk
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.